Article Text

Download PDFPDF
British Society for Rheumatology guideline for diagnosis and treatment of giant cell arteritis

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Twitter Susan P Mollan @DrMollan.

  • Contributors SPM drafted and revised the script. SLM revised the script for intellectual content. Both read and approved the final manuscript.

  • Funding SLM receives infrastructure support from the MRC TARGET Partnership Grant (MR/N011775/1/MRC_/Medical Research Council/United Kingdom)

  • Competing interests SPM has received advisory board and speaker fees from Roche (2016–2019); speaker fees from Chugai-Roche Ltd (2017–2019) and advisory board fees from Janssen (2020). She has acted as an investigator on aclinical trial in GCA for Roche. SLM received consultancy fees from Roche (2015) and was supported by Roche to attend EULAR 2019. She has acted as an investigator on clinical trials in GCA for Sanofi, Roche and GSK. Consultancy fees from Roche (2016, 2018) and Sanofi (2017) were paid to her institution. She is Patron of the UK charity PMRGCAuk.

  • Patient consent for publication Not required.

  • Data sharing statement There is no unpublished data.

  • Provenance and peer review Not commissioned; externally peer reviewed Nicola Giffin, Bath, UK.

Other content recommended for you